Natural killer cell-mediated innate sieve effect on HIV-1: The impact of KIR/HLA polymorphism on HIV-1 subtype-specific acquisition in East Africa

Journal of Infectious Diseases

Volumn 208, Issue 8, 2013, Pages 1250-1254

  Koehler, Rebecca N ^a,b   Alter, Galit ^c   Tovanabutra, Sodsai ^a,b   Saathoff, Elmar ^d   Arroyo, Miguel A ^a   Walsh, Anne M ^a,b   Sanders Buell, Eric E ^a,b   Maboko, Leonard ^e   Hoelscher, Michael ^d,e   Robb, Merlin L ^a,b   Michael, Nelson L ^a   McCutchan, Francine E ^a,b   Kim, Jerome H ^a   Kijak, Gustavo H ^a,b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d UNIVERSITY OF MUNICH   (Germany)

^e NIMR Mbeya Medical Research Programme   (Tanzania)

Author keywords

East Africa; HIV 1; HLA; innate immunity; KIR; sieve effect; subtypes

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

AFRICA; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INNATE IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; VIRUS REPLICATION; VIRUS STRAIN;

EAST AFRICA; HIV-1; HLA; INNATE IMMUNITY; KIR; SIEVE EFFECT; SUBTYPES;

GENOTYPE; HIV INFECTIONS; HIV SEROPREVALENCE; HIV-1; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; ODDS RATIO; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RECEPTORS, KIR; TANZANIA;

EID: 84885062929     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit349     Document Type: Article

References (15)

1. Kijak GH, McCutchan FE. HIV diversity, molecular epidemiology, and the role of recombination. Curr Infect Dis Rep 2005; 7:480-8.
2. Arroyo MA, Hoelscher M, Sateren W, et al. HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania. AIDS 2005; 19:1517-24.
3. Thomson MM, Najera R. Travel and the introduction of human immunodeficiency virus type 1 non-B subtype genetic forms into Western countries. Clin Infect Dis 2001; 32:1732-7.
4. Single RM, Martin MP, Gao X, et al. Global diversity and evidence for coevolution of KIR and HLA. Nat Genet 2007; 39:1114-9.
5. Prugnolle F, Manica A, Charpentier M, Guegan JF, Guernier V, Balloux F. Pathogen-driven selection and worldwide HLA class I diversity. Curr Biol 2005; 15:1022-7.
6. Bashirova AA, Thomas R, Carrington M. HLA/KIR restraint of HIV: Surviving the fittest. Annu Rev Immunol 2011; 29:295-317.
7. Cella M, Longo A, Ferrara GB, Strominger JL, Colonna M. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 1994; 180:1235-42.
8. Alter G, Martin MP, Teigen N, et al. Differential natural killer cellmediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 2007; 204:3027-36.
9. Alter G, Heckerman D, Schneidewind A, et al. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 2011; 476:96-100.
10. Koehler RN, Walsh AM, Saathoff E, et al. Class I HLA-A.*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania. J Infect Dis 2010; 202:1562-6.
11. Koehler RN, Walsh AM, Moqueet N, et al. High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR. Tissue Antigens 2009; 74:73-80.
12. Tovanabutra S, Kijak GH, Beyrer C, et al. Identification of CRF34-01B, a second circulating recombinant form unrelated to and more complex than CRF15-01B, among injecting drug users in northern Thailand. AIDS Res Hum Retroviruses 2007; 23:829-33.
13. Boulet S, Sharafi S, Simic N, et al. Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. AIDS 2008; 22: 595-9.
14. Guerini FR, Lo Caputo S, Gori A, et al. Under representation of the inhibitory KIR3DL1 molecule and the KIR3DL1+/BW4+ complex in HIV exposed seronegative individuals. J Infect Dis 2011; 203: 1235-9.
15. Haase AT. Early events in sexual transmission of HIV and SIV and opportunities for interventions. Annu Rev Med 2011; 62:127-39.